Sun Pharma numbers were slightly below expectations in terms of EBITDA and we do think that though they have guided for a very strong growth through their speciality portfolio, that is a little bit time away.
RIL vs Airtel: Hemang Jani explains how to approach both
Elon Musk’s SpaceX plans to enter India’s telecom sector with Starlink, intensifying competition between Bharti Airtel and Reliance. Market expert Hemang Jani suggests Reliance offers